One Stop Solution For In-Depth Market Research Reports

詳細な市場調査レポートのワンストップソリューション

Home    >    HEALTHCARE AND PHARMACEUTICALS   >   Creatinine Measurement Market

[ 英語タイトル ] Creatinine Measurement Market by Product (Kits, Reagents), Test Type (Jaffe method, Enzymatic creatinine method), Sample (Serum Creatinine, Urine) and End User (Hospitals, Diagnostic Laboratories), Region (North America, Europe) - Global Forecast to 2023


Product Code : MNMHC00109899
Survey : MarketsandMarkets
Publish On : February, 2021
Category : Healthcare and Pharmaceuticals
Study Area : Global
Report format : PDF
Sales price option (consumption tax not included)
Single User USD5650 / Question Form
5 User USD6650 / Question Form
Enterprise User USD10000 / Question Form

[Report Description]

“The global creatinine measurement market projected to grow at a CAGR of 8.4%.”
The global creatinine measurement market is expected to reach USD 564.5 million by 2023 from USD 377.2 million in 2018, at a CAGR of 8.4%.

Factors such as the increasing incidence of renal disorders, growing incidence of other chronic disorders impacting renal function, favorable government initiatives to promote renal health, rapid growth in the geriatric population, and the increasing number of drug development initiatives are driving the growth of the creatinine test kits and reagents market. On the other hand, identification of novel renal dysfunction biomarkers and frequently changing regulatory policies are expected to restrain the growth of this market to a certain extent.

“Enzymatic method is expected to grow at the highest CAGR during the forecast period.”
Based on test type, the market is segmented into is segmented into Jaffe’s kinetic method and enzymatic method. The enzymatic method segment is expected to grow at the highest CAGR during the forecast period owing to the advantages offered by this method such as high accuracy and specificity, low sample volume, and lack of interfering substances.

“Blood/serum is expected to dominate the market during the forecast period.”
Based on type of sample the creatinine measurement market is segmented into blood/serum and urine samples. The blood/serum segment is expected to hold the largest share of the market and is also projected to grow at the highest CAGR during the forecast period. The large share of the blood/serum segment is primarily attributed to the benefits offered by this sample type, such as increased accuracy and low risk of contamination.

“In 2018, hospitals segment is expected to account for the largest share of the market.”
On the basis of end user, the creatinine measurement market is segmented into hospitals and diagnostic laboratories. In 2018, the hospitals segment is expected to account for the largest share of the creatinine measurement market. High patient influx, regular monitoring of kidney function by physicians (of patients with various disorders impacting kidney function) at hospitals, and the presence of an established and advanced diagnostic infrastructure are some of the major factors responsible for the large share of this end-user segment.

“Asia to witness the highest growth during the forecast period.”
In 2018, North America is expected to account for the largest share of the market followed by Europe. However, Asia is expected to register the highest CAGR during the forecast period. The growing prevalence of CKD, rising awareness about preventive healthcare, improving healthcare infrastructure, and growing focus of market players on addressing the demands in several Asian countries are the key factors driving the market growth in Asia. Also, as developed markets are reaching saturation levels, Asia is expected to become a hotspot for creatinine test kit providers.
The primary interviews conducted for this report can be categorized as follows:
• By Company Type: Tier 1 – 32%; Tier 2 - 44%; Tier 3 - 24%
• By Designation C-level- 23%; D-level- 26%; Others- 51%
• By Region: North America-59%; Europe-14%; Asia -22%; Rest of the World-5%

List of companies profiled in the report
• F. Hoffmann-la Roche Ltd (Switzerland)
• Abbott Laboratories (US)
• Danaher Corporation (US)
• Thermo Fisher Scientific Inc (US)
• Siemens Healthineers (Germany)
• Randox Laboratories (UK)
• Pointe Scientific, Inc (US)
• Sentinel Ch. Spa. (Italy)
• Diasys Diagnostic Systems GmbH (Germany)
• Dialab GmbH (Vienna)
• Diazyme Laboratories, Inc (US)
• Wako Pure Chemical Industries Ltd(Japan))
• Ortho Clinical Diagnostics (US)
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd (China)
Research Coverage:
The report provides an overview of the creatinine measurement market. It aims at estimating the market size and future growth potential of this market across different segments such as test type, type of sample, end user, and region. Furthermore, the report also includes an in-depth competitive analysis of the key players in the market along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:
The report will help the market leaders/new entrants in this market by providing them with the closest approximations of revenues for the overall creatinine measurement market and its subsegments. This report will help stakeholders to understand the competitive landscape better and gain insights to position their businesses and help companies make suitable go-to-market strategies. The report also will also help stakeholders understand the pulse of the market and provide them with information regarding key market drivers and opportunities.

TABLE OF CONTENTS

1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.4 LIMITATIONS
1.5 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 INTRODUCTION
2.2 RESEARCH DATA
2.3 MARKET SIZE ESTIMATION: CREATININE TEST KITS AND REAGENTS MARKET
2.3.1 BOTTOM-UP APPROACH
2.3.2 TOP-DOWN APPORACH
2.4 BREAKDOWN OF PRIMARIES: CREATININE TEST KITS AND REAGENTS MARKET
2.5 MARKET BREAKDOWN AND DATA TRIANGULATION: CREATININE TEST KITS AND REAGENTS MARKET
2.6 SECONDARY DATA
2.6.1 KEY DATA FROM SECONDARY SOURCES
2.7 PRIMARY DATA
2.7.1 KEY DATA FROM PRIMARY SOURCES
2.8 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DRIVERS
5.2.1 INCREASING INCIDENCE OF RENAL DISORDERS
5.2.2 GROWING INCIDENCE OF OTHER CHRONIC DISORDERS IMPACTING
RENAL FUNCTION
5.2.3 GROWING AWARENESS AND ADOPTION OF PREVENTIVE HEALTHCARE
5.2.4 FAVORABLE GOVERNMENT INITIATIVES TO PROMOTE RENAL HEALTH
5.2.5 RAPID GROWTH IN THE GERIATRIC POPULATION
5.2.6 INCREASING NUMBER OF DRUG DEVELOPMENT INITIATIVES

5.3 MARKET RESTRAINTS/CHALLENGES
5.3.1 IDENTIFICATION OF NOVEL RENAL DYSFUNCTION BIOMARKERS
5.3.2 FREQUENTLY CHANGING REGULATORY POLICIES

5.4 MARKET OPPORTUNITIES
5.4.1 HIGH GROWTH POTENTIAL IN EMERGING ECONOMIES
5.4.2 COMMERCIALIZATION OF ADVANCED TESTING METHODS
6 CREATININE TEST KITS AND REAGENTS MARKET, BY PRODUCT
6.1 INTRODUCTION
6.2 REAGENTS
6.3 KITS
7 CREATININE TEST KITS AND REAGENTS MARKET, BY TYPE
7.1 INTRODUCTION
7.2 JAFFE’S KINETIC METHOD
7.3 ENZYMATIC METHOD
8 CREATININE TEST KITS AND REAGENTS MARKET, BY SAMPLE TYPE
8.1 INTRODUCTION
8.2 BLOOD/SERUM
8.3 URINE
9 CREATININE TEST KITS AND REAGENTS MARKET, BY END USER
9.1 INTRODUCTION
9.2 HOSPITALS
9.3 DIAGNOSTIC LABORATORIES
10 CREATININE TEST KITS AND REAGENTS MARKET, BY REGION
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 U.S.
10.2.2 CANADA
10.3 EUROPE
10.3.1 GERMANY
10.3.2 UK
10.3.3 FRANCE
10.3.4 REST OF THE EUROPE
10.4 ASIA
10.4.1 JAPAN
10.4.2 CHINA
10.4.3 INDIA
10.4.4 INDONESIA
10.4.5 REST OF THE ASIA
10.5 REST OF THE WORLD
10.5.1 BRAZIL
10.5.2 OTHER ROW COUNTRIES
11 COMPETITIVE LANDSCAPE
11.1 CREATININE TEST KITS AND REAGENTS MARKET: COMPETITIVE INTELLIGENCE (2017)
11.2 CREATININE TEST KITS AND REAGENTS MARKET: MARKET SHARE ANALYSIS (2017)
11.3 CREATININE TEST KITS AND REAGENTS MARKET: COMPETETIVE SITUATION & TRENDS
12 COMPANY PROFILES
12.1 INTRODUCTION
12.2 SIEMENS HEALTHINEERS (A DIVISION OF SIEMENS AG)
12.3 F. HOFFMANN-LA ROCHE LTD.
12. 4 ABBOTT LABORATORIES
12. 5 DANAHER CORPORATION (BECKMAN COULTER)
12.6 THERMO FISHER SCIENTIFIC INC.
12.7 RANDOX LABORATORIES
12.8 WAKO PURE CHEMICAL INDUSTRIES, LTD
12.9 POINTE SCIENTIFIC, INC (A PART OF MEDTEST HOLDINGS)
12.10 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD
12.11 ORTHO CLINICAL DIAGNOSTICS
12.12 DIAZYME LABORATORIES, INC
12.13 DIALAB GMBH
12.14 SENTINEL CH. SPA
12.15 DIASYS DIAGNOSTIC SYSTEMS GMBH


13 APPENDIX
13.1 KEY INDUSTRY INSIGHTS
13.2 DISCUSSION GUIDE
13.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.4 MARKETSANDMARKETS KNOWLEDGE STORE: SNAPSHOT
13.5 INTRODUCING RT: REAL TIME MARKET INTELLIGENCE
13.6 RELATED REPORTS
13.7 AUTHOR DETAILS

渋谷データカウント

渋谷データカウントは、最も信頼性が高く最新の調査分析レポートを確実に提供する経験豊富な調査専門家のグローバルチームが提供する、さまざまな業界のさまざまな市場調査レポートを提供する再販代理店です。

Recommended reports

+